Rectal Neoplasms: Clinical Trials

12 trials for Rectal Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 2 active not recruiting, 2 recruiting, 1 completed. 12 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 112Terminated 4, Active not recruiting 2, Recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Rectal Neoplasms: new trials by email Literature Review of Rectal Neoplasms trials Research Report on Rectal Neoplasms

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer
SCRT+Capoex+QL706, LCRT+Capoex+QL706 - Rectal Cancer
Early Phase 1Not yet recruitingChanghai Hospital602025-05-202025-04-17
PET-imaging of Two Vartumabs in Patients With Solid Tumors
89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma
Early Phase 1RecruitingVar2 Pharmaceuticals322024-12-102025-12-29
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
Chemotherapy, Patient Observation, Questionnaire Administration - Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8
Early Phase 1RecruitingM.D. Anderson Cancer Center1202024-03-132026-11-17
Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy
MIYAIRI 588 - Ileostomy - Stoma, Rectal Cancer
Early Phase 1UnknownHuashan Hospital642023-01-172023-03-14
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A, Imaging Technique - Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8
Early Phase 1Active not recruitingCity of Hope Medical Center142022-08-312026-06-08
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
Capecitabine, Radiation Therapy, FOLFOX regimen - Rectal Adenocarcinoma
Early Phase 1Active not recruitingH. Lee Moffitt Cancer Center and Research Institute202021-12-232026-04-01
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm
Early Phase 1TerminatedMayo Clinic22019-11-082025-02-20
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
Contrast-enhanced Magnetic Resonance Imaging, Ferumoxytol - Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7
Early Phase 1TerminatedOHSU Knight Cancer Institute22018-04-272021-09-10
Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
cholecalciferol, biopsy, protein expression analysis - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Early Phase 1WithdrawnCase Comprehensive Cancer Center2012-04-012014-01-17
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
cetuximab, dasatinib, therapeutic conventional surgery - Liver Metastases, Mucinous Adenocarcinoma of the Colon
Early Phase 1TerminatedNational Cancer Institute (NCI)92009-12-012014-05-23
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
colloidal gold-bound tumor necrosis factor, electron microscopy, pharmacological study - Adrenocortical Carcinoma, Breast Cancer
Early Phase 1CompletedNational Institutes of Health Clinical Center (CC)1082006-12-012012-05-02
Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine - Colorectal Cancer
Early Phase 1TerminatedCraig L Slingluff, Jr112003-03-242020-03-30

Narrower conditions

Colonic Neoplasms (7)  ·  Sarcoma (3)  ·  Breast Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Adrenocortical Carcinoma (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Renal Cell (1)  ·  Chondrosarcoma (1)  ·  Desmoplastic Small Round Cell Tumor (1)

Broader conditions

Digestive System Diseases (12)  ·  Digestive System Neoplasms (12)  ·  Gastrointestinal Diseases (12)  ·  Intestinal Diseases (12)  ·  Intestinal Neoplasms (12)  ·  Neoplasms by Site (12)  ·  Rectal Diseases (12)  ·  Gastrointestinal Neoplasms (11)  ·  Neoplasms (11)  ·  Colorectal Neoplasms (10)  ·  Colonic Diseases (7)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)

Interventions

X-Rays (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Biopsy (1)  ·  CYT-6091 (1)  ·  Capecitabine (1)  ·  Cetuximab (1)  ·  Cholecalciferol (1)  ·  Cisplatin (1)  ·  Copper (1)  ·  Cytoreduction Surgical Procedures (1)  ·  Dasatinib (1)  ·  Doxorubicin (1)  ·  Drug Therapy (1)  ·  Enzyme-Linked Immunosorbent Assay (1)  ·  Ferrosoferric Oxide (1)

Sponsors

Case Comprehensive Cancer Center (1)  ·  Changhai Hospital (1)  ·  City of Hope Medical Center (1)  ·  Craig L Slingluff, Jr (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Huashan Hospital (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  OHSU Knight Cancer Institute (1)  ·  Var2 Pharmaceuticals (1)

Countries

United States (8)  ·  China (1)  ·  Netherlands (1)

Top investigators

Alexander Guimaraes (1)  ·  Charles M. Friel, MD (1)  ·  Emily Chan (1)  ·  George Chang (1)  ·  Gooitzen van Dam, MD, PhD (1)  ·  Jeffrey Y Wong (1)  ·  Jessica M Frakes, MD (1)  ·  Matthew Kalady, MD (1)  ·  Patricio C. Gargollo, M.D. (1)  ·  Seth Felder, MD (1)  ·  Smitha Krishnamurthi, MD (1)  ·  Steven A. Rosenberg, MD, PhD (1)

Results publications

PMID 37344887

NIH funding

P30CA033572 (1), P30CA068485 (1)